ArticleThe Lancet. Oncology2012
Menarche, menopause, and breast cancer risk.
Article in The Lancet. Oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A meta-analysis of reference values of leptin concentration in healthy postmenopausal women.PloS one · 2013Pooled it
- Development and validation of a nomogram for predicting axillary reverse mapping lymph node metastasis in breast cancer patients.Frontiers in oncology · 2026Article
- Artificial Intelligence in Postmenopausal Health: From Risk Prediction to Holistic Care.Journal of clinical medicine · 2025Review
- Clinical significance of FOXN3 expression in Indian breast cancer patients.Scientific reports · 2025Article
- Mammalian Species-Specific Resistance to Mammary Cancer.Journal of mammary gland biology and neoplasia · 2025Review
- Article
- Reproductive Risk Factor Patterns in Caribbean Women With Breast Cancer Across 4 Generations.JAMA network open · 2024Observational
- Association of early menarche with breast tumor molecular features and recurrence.Breast cancer research : BCR · 2024Article
- A life-course approach to tackling noncommunicable diseases in women.Nature medicine · 2024Review
- Article
- Clinicopathological Features of Breast Cancer in Relation to Exposure of Cycling Reproductive Hormones: A Multicenter Retrospective Study of 14,731 Patients Diagnosed with Invasive Breast Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2022Article
- Correlation of MSH2 exonic deletions and protein downregulation with breast cancer biomarkers and outcome in Pakistani women/patients.Environmental science and pollution research international · 2021Article
- Time Trends in Age at Menarche and Related Non-Communicable Disease Risk during the 20th Century in Mexico.Nutrients · 2019Article
- Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: A nationwide retrospective cohort study.PloS one · 2019Article
- Pros and cons of GnRHa treatment for early puberty in girls.Nature reviews. Endocrinology · 2014Review
- Endocrine disruption of the epigenome: a breast cancer link.Endocrine-related cancer · 2014Review
- Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer.Technology in cancer research & treatmentReview
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
23084520What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.